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The severe acute respiratory syndrome coronavirus (SARS-CoV) genome contains open reading frames
(ORFs) that encode for several genes that are homologous to proteins found in all known coronaviruses. These
are the replicase gene 1a/1b and the four structural proteins, nucleocapsid (N), spike (S), membrane (M), and
envelope (E), and these proteins are expected to be essential for the replication of the virus. In addition, this
genome also contains nine other potential ORFs varying in length from 39 to 274 amino acids. The largest
among these is the first ORF of the second longest subgenomic RNA, and this protein (termed U274 in the
present study) consists of 274 amino acids and contains three putative transmembrane domains. Using
antibody specific for the C terminus of U274, we show U274 to be expressed in SARS-CoV-infected Vero E6 cells
and, in addition to the full-length protein, two other processed forms were also detected. By indirect immu-
nofluorescence, U274 was localized to the perinuclear region, as well as to the plasma membrane, in both
transfected and infected cells. Using an N terminus myc-tagged U274, the topology of U274 and its expression
on the cell surface were confirmed. Deletion of a cytoplasmic domain of U274, which contains Yxx and
diacidic motifs, abolished its transport to the cell surface. In addition, U274 expressed on the cell surface can
internalize antibodies from the culture medium into the cells. Coimmunoprecipitation experiments also
showed that U274 could interact specifically with the M, E, and S structural proteins, as well as with U122,
another protein that is unique to SARS-CoV.
The recent severe acute respiratory syndrome (SARS) epi-
demic, which affected over 30 countries, has profoundly dis-
turbed social and economic activities regionally, as well as
globally. A novel coronavirus was identified as the etiological
agent of SARS (13, 14, 23, 36). Analysis of the nucleotide
sequence of this novel SARS coronavirus (SARS-CoV)
showed that the viral genome is nearly 30 kb in length and
contains 14 potential open reading frames (ORFs) (31, 38, 52).
Coronaviruses are positive-strand RNA viruses, and the virion
consists of a nucleocapsid core surrounded by an envelope
containing three membrane proteins—spike (S), membrane
(M), and envelope (E)—that are common to all members of
the genus (for reviews, see references 12, 24, 25, and 43). The
RNA is packaged by the nucleocapsid (N) protein into a he-
lical nucleocapsid (for a review, see reference 26). The S pro-
tein, which forms morphologically characteristic projections on
the virion surface, mediates binding to host receptors and
membrane fusion (for a review, see reference 9). The M pro-
tein is a triple-spanning integral membrane protein with a
short ectodomain and a large carboxyl-terminal endodomain
(for a review, see reference 39). More recently, the E protein
was showed to play a major role in coronavirus assembly (2, 4,
10, 15, 27, 59, 60). Another structural protein, the hemagglu-
tinin esterase glycoprotein (HE), is found in only a subset of
coronaviruses, but its role in the virus life cycle has not been
well established (for a review, see reference 7). The SARS-
CoV genome does not appear to encode for a HE protein (38).
The genes for these structural proteins and the replicase
1a/1b gene, which is located at the 5 end of the genome and
constitutes two-thirds of it, are conserved among the sub-
groups of coronavirus so is their relative position in the ge-
nome (for reviews, see references 12, 25, 26, and 43). In addi-
tion, there are subgroup-specific accessory proteins that vary in
size and position in the genome. These proteins are usually
dispensable for viral replication, at least in the cell culture
system, but may be important for virus-host interactions and
thus contribute to viral fitness (for reviews, see references 8,
12, 24, and 28). For example, although the 7b gene of feline
coronavirus is easily lost upon virus adaptation to cell culture,
it is strictly maintained in naturally occurring strains, and its
loss was correlated with reduced virulence (18, 58). A recent
study also showed that some of the group-specific murine coro-
navirus genes are not essential for viral replication in cell
culture, but their deletion, by reverse genetics, is attenuating in
the natural host (11).
Initially, phylogenetic analysis of the SARS-CoV genome
suggested that it does not belong to any of the preexisting
coronavirus subgroups (31, 38). However, more extensive stud-
ies revealed that SARS-CoV is distantly related to the estab-
lished group 2 coronaviruses (45). In addition to the replicase
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gene 1a/1b and the four structural proteins (S, E, M, and N), it
contains another nine potential ORFs varying in length from
39 to 274 amino acids (aa) (31, 38, 52). Whether these ORFs
are expressed or not and whether the expressed proteins are
essential for viral replication awaits elucidation. The largest
among these is the first ORF of the second-largest subgenomic
RNA (sgRNA), which is 4.5 kbp in length. This sgRNA
(termed sgRNA3) is found in high abundance in infected cells
and contains a strong match to the transcription regulating
consensus sequence close to and upstream of its first ORF (31,
38, 52). We have termed this protein U274 for unique protein
of 274 aa since it does not show significant similarities to any
known protein, although a region in its C terminus shows
similarity to calcium-transporting adenosine triphosphatases
(note that this ORF is named ORF3 in reference 31, X1 in
reference 38, and ORF3a in references 45 and 52). Previously,
we have analyzed 81 sera obtained from SARS patients in
Singapore and found that most of the sera, particularly those
from convalescent patients, contain antibodies against the
U274 protein, suggesting that U274 could play an important
role in the biogenesis of SARS-CoV (51).
In the present study, we used specific antibodies against
U274 to show that it is indeed expressed in SARS-CoV-in-
fected cells. Moreover, we further characterized its cellular
localization and topology, as well as the effects of sorting sig-
nals in its C terminus cytoplasmic domain on its transport
properties. The ability of U274 to interact with other SARS-
CoV proteins was also determined.
MATERIALS AND METHODS
Materials. All reagents used in the present study were purchased from Sigma
(St. Louis, Mo.) unless otherwise stated. The 293T, HeLa, and Vero E6 cell lines
were purchased from the American Type Culture Collection (Manassas, Va.)
and cultured at 37°C in 5% CO2 in Dulbecco modified Eagle medium containing
1 g of glucose/liter, 2 mM L-glutamine, 1.5 g of sodium bicarbonate/liter, 0.1 mM
nonessential amino acids, 0.1 mg of streptomycin/ml, 100 U of penicillin, and 5%
fetal bovine serum (HyClone Laboratories, Inc., Logan, Utah).
Construction of plasmids. For transient expression in mammalian cells, the
vectors used were pXJ40HA and pXJ40myc for tagging proteins at the N ter-
minus with a hemagglutinin (HA) or c-myc epitope, respectively, and pXJ40-
3HA for tagging proteins with three HA epitopes at the C terminus (GLAXO
Group, Institute of Molecular and Cell Biology, Singapore [unpublished data]).
For untagged U274, the pXJ40-3HA vector was used, but a stop codon was
inserted before the HA epitopes at the C terminus so that these epitopes would
not be expressed.
The various viral genes used in the present study were obtained from SARS-
CoV 2003VA2774, an isolate from a SARS patient in Singapore, as previously
described (51). Briefly, RNA was extracted from SARS-CoV-infected Vero E6
cell culture supernatant, reverse transcribed, and used as a template in PCR with
specific primers. Two mutated forms of U274 were used in the present study:
U274mut1 and U274mut2. U274mut1 corresponds to 101 to 274 aa of U274, and
this construct was obtained by PCR. U274mut2 corresponds to U274 with 160 to
173 aa (YNSVTDTIVVTEGD) deleted, and this construct was obtained by two
rounds of PCR.
The sequences of all constructs used in the present study were confirmed by
DNA sequencing performed at the core facility at the Institute of Molecular and
Cell Biology by using the dideoxy method with the Taq DyeDeoxy terminator
cycle sequencing kit and the automated DNA sequencer 373 from PE Applied
Biosystems (Foster City, Calif.).
Raising polyclonal antibody against U274. Glutathione S-transferase (GST)-
U274(134-274) protein was expressed as previously described (51) and used to
immunize a New Zealand White rabbit as previously described (47). This region
corresponds to the C-terminal hydrophilic domain of U274. The final bleeding
was carried out 10 days after the 10th injection, and the serum was used directly
in the present study.
Transient transfection of mammalian cells and Western blot analysis. Tran-
sient-transfection experiments were performed by using Lipofectamine reagent
(Invitrogen, Carlsbad, Calif.) according to manufacturer’s protocol. Typically,
106 cells were plated on 6-cm dish and allowed to attach overnight. Then, 1 to
3 g of DNA was used per plate, and the cells were left for at least 16 h before
the cells were washed with phosphate-buffered saline (PBS) and then lysed
directly in Laemmli’s sodium dodecyl sulfate (SDS) buffer and used for Western
blot analysis. Approximately, 105 transfected cells were separated on SDS-
polyacrylamide gel and transferred to nitrocellulose Hybond-C membrane (Am-
ersham Pharmacia Biotech, Uppsala, Sweden). The membranes were blocked
with 5% nonfat dry milk for 30 min, followed by overnight incubation at 4°C with
the primary antibody. The membranes were then washed extensively with PBST
(PBS containing 0.05% Tween 20), followed by incubation with an appropriate
horseradish peroxidase-conjugated secondary antibody (Pierce, Rockford, Ill.)
for 1 h at room temperature, washing, and detection by an enhanced chemilu-
minescence method (Pierce). The primary antibodies used were anti-HA poly-
clonal (Y-11), anti-myc polyclonal (A-14), and anti-myc monoclonal (9E10)
antibodies (Santa Cruz Biotechnology, Santa Cruz, Calif.); anti-HA monoclonal
antibody (12CA5; Roche Molecular Biochemicals, Indianapolis, Ind.); anti-actin
antibody (AC-15; Sigma); anti-U274 rabbit polyclonal antibody (the present
study); and anti-human transferrin receptor (TfR; BD Pharmingen, San Diego,
Calif.).
When it was necessary to reprobe a membrane with another antibody, the
membrane was stripped with stripping buffer (2% SDS, 100 mM -mercapto-
ethanol, 62.5 mM Tris-HCl [pH 6.8]) for 30 min at 65°C and washed extensively
with PBST before use.
Infection of Vero E6 cells with SARS-CoV. SARS-CoV 2003VA2774, an iso-
late from a SARS patient in Singapore, was used to infect Vero E6 cells as
previously described (33, 40, 51). Briefly, the virus stock used in the present study
was from the third passage of the isolate, and the titer was 107 PFU ml1. For
the present study, monolayer of cells were infected at multiplicity of infection
(MOI) of 1, and at approximately 8 h postinfection the cells showed 25%
cytopathic effect (CPE). For another set of experiments, the cells were infected
at an MOI of 0.1 and, at approximately 24 h postinfection, the cells showed 75%
CPE. At these two time points (i.e., 25 and 75% CPE), the cells were washed with
PBS and then lysed in 600 l (for each 180-cm2 flask) of lysis buffer containing
50 mM Tris-HCl (pH 8), 150 mM NaCl, 0.5% NP-40 (BDH Laboratory Sup-
plies), 0.5% sodium deoxycholate, and 0.005% SDS. A total of 20 l of the lysate
was used for Western blot analysis as described above.
For RNA extraction, infected cells were washed with PBS, and then total RNA
was extracted with TRIzol reagent (Invitrogen) according to the manufacturer’s
protocol. The RNA was subjected to first strand cDNA synthesis with oli-
go(dT)20 primers and Superscript III RT (Invitrogen) according to the manu-
facturer’s protocol. This product was used as a template for the first PCR. The
first PCR (total volume of 25 l) was carried out with the first set of primers
(PCRfor1, ACCCAGGAAAAGCCAACCAACCTC [bp 2 to 25]; PCRrev1, AA
TGCCGTCACCTTCAGTAACGAC [bp 25776 to 25753]), and the second
round of PCR was then performed with the second set of primers (PCRfor1 and
PCRrev2, TTGTAGCGGTATCGTTGCTGTAGC [bp 25365 to 25342]) with 1
l of the first PCR as a template in a total volume of 25 l. These primers
correspond to regions in the SARS-CoV genome (and the base pair numbering
is given with reference to the 2003VA2774/SIN2774 isolate [GenBank accession
no. AY28379]), which are close to the U274 encoding sequence. All PCRs were
performed with High-Fidelity Taq Polymerase (Roche), and the PCR conditions
were as follows: 95°C for 5 min, followed by 35 cycles of 95°C for 15 s, 60°C for
15 s, and 72°C for 30 s, with a final extension at 72°C for 10 min. Nested PCR
products were cloned into the TOPO TA cloning vector, pCRII-TOPO (Invitro-
gen), and 15 independent clones were sequenced as described above.
For immunofluorescence, Vero E6 cells were infected with SARS-CoV at an
MOI of 1 and grown on coverslips (Iwaki; Asahi Techno Glass, Tokyo, Japan)
until the cells showed a CPE of ca. 25%. The medium was removed, and the
coverslips were fixed in acetone for 20 to 30 min on ice. The acetone was then
removed, and the coverslips were completely air dried and stored at 20°C until
use. Before use, the coverslips were fixed again with 4% paraformaldehyde,
permeabilized with Triton X-100, and incubated with antibodies as described
below.
Comparison of U274 protein sequences of different SARS-CoV isolates. Se-
quences of U274 were obtained from the different SARS-CoV isolates reported
in the GenBank database and aligned by using MegAlign software (DNAStar,
Inc., Madison, Wis.). The isolates used were TOR2 (AY274119), Urbani
(AY278741), CUHK-W1 (AY278554), BJ01 (AY278488), HKU-39849
(AY278491), BJ02 (AY278487), BJ03 (AY278490), BJ04 (AY279354), GZ01
(AY278489), SIN2679 (AY283796), SIN2500 (AY283794), ZJ01 (AY297028),
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SIN2677 (AY283795), TW1 (AY29145), CUHK-Su10 (AY282752), SIN2748
(AY283797), SIN2774 (AY283798), Frankfurt1 (AY291315), SZ1 (AY304489),
SZ3 (AY304486), SZ13 (AY304487), and SZ16 (AY304488).
Indirect immunofluorescence. For transient transfection, cells grown on Per-
manox slide (Nalge Nunc International, Naperville, Ill.) were transfected as
described above. The cells were then fixed with 4% paraformaldehyde for 10 min
at room temperature and used directly or subjected to permeabilization with
either digitonin (50 g/ml; Sigma) or Triton X-100 (0.2%; BDH Laboratory
Supplies, Poole, England) for 10 min at room temperature. Cells were blocked
with PBS plus 1% bovine serum albumin (BSA) for 30 min and then incubated
with the primary antibody (1:200) for 1.5 h, washed, and then incubated with
fluorescein isothiocyanate (FITC)-conjugated or rhodamine-conjugated second-
ary antibody (1:200; Santa Cruz) for 1 h. All incubations and washes were
performed at room temperature. Slides were mounted with FluorSave reagent
(Oncogene Research Products, Cambridge, Mass.) and analyzed on a MRC1024
laser confocal microscope (Hercules, Calif.).
FACS analysis. To determine the expression of proteins on the surface of live
Vero E6 cells, fluorescence-activated cell sorting (FACS) analyses were per-
formed as previously described (49, 50). Briefly, cells were treated with trypsin
ca. 24 h after transfection, washed twice with PBS plus 1% BSA, and then
incubated with an anti-myc monoclonal antibody (2.5 g/ml; Santa Cruz Bio-
technology) or an isotype-matched control (anti-Bcl-2, clone 100, immunoglob-
ulin G1; Santa Cruz Biotechnology) for 4 h at 4°C. The cells were then washed
three times with cold PBS plus 1% BSA and incubated with a goat FITC-
conjugated anti-mouse F(ab)2 antibody (15 g/ml; Pierce) for 2 h at 4°C. Cells
were washed as before and analyzed on a Becton Dickinson flow cytometer (San
Jose, Calif.).
Internalization experiments. To determine whether cell surface U274 can
undergo endocytosis, internalization experiments were performed as previously
described (49). Briefly, 5  105 cells (Vero E6 or HeLa) were plated on six-well
plates and allowed to settle overnight. If required, transient transfection with
pXJ40myc-U274, pXJ40myc-GST, or pXJ40-TfR (for expressing full-length hu-
man TfR protein; HWJ Laboratory, Institute of Molecular and Cell Biology,
Singapore [unpublished data]) was performed as described above, and the cells
were left for another 16 to 24 h. Then, 0.5 ml of a 2.5-g/ml concentration of the
appropriate antibody (anti-c-myc; Santa Cruz Biotechnology) or anti-human
CD81 (Santa Cruz Biotechnology) or anti-human TfR (BD Pharmingen) mono-
clonal antibody was overlaid onto the cells for 3 h at 37°C. The plate was then
cooled on ice for 10 min before any unbound antibody was removed with three
washes of cold PBS plus 1% BSA. For experiments that involved the removal of
surface-bound antibodies, the cells were further incubated with cold acid (0.2 M
acetic acid [pH 2.0]–0.5 M NaCl) (17) for 10 min, followed by PBS washes.
Finally, cells were harvested,d lysed in Laemmli SDS buffer (containing 10 mM
dithiothreitol and 20 mM -mercaptoethanol [BDH Laboratory Supplies]), and
subjected to Western blot analysis.
Coimmunoprecipitation experiments. 293T cells were transiently transfected
with pXJ40myc-GST or XJ40myc-U274 and the various HA-tagged constructs or
pXJ3-S(stop), which does not contain any tags. After ca. 16 to 24 h, the cells
were harvested and used in coimmunoprecipitation experiments as previously
described (48), except that the reaction buffer used here contained 10 mM
HEPES (pH 7.2), 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, and 1%
NP-40. Briefly, the lysate was incubated with an anti-myc polyclonal antibody
(Santa Cruz Biotechnology) for 2 h at 4°C, followed by adsorption onto 10 l of
protein A-Sepharose beads (Roche). The beads were then washed three times
with cold reaction buffer and subjected to Western blot analysis.
RESULTS
Polyclonal antibodies to the SARS-CoV unique protein
U274. The first protein encoded by the second-largest sgRNA
(termed sgRNA3 as in reference 52) of the SARS-CoV con-
sists of 274 aa and contains three putative transmembrane
domains (Fig. 1A; this ORF is named ORF3 in reference 31,
X1 in reference 38, and ORF3a in references 45 and 52), and
we refer to it as U274 here. The C terminus hydrophilic do-
main (134 to 274 aa) of U274 was expressed as a GST fusion
protein as previously described (51) and used to raise rabbit
polyclonal antibodies. To determine the specificity of the an-
tibody, U274, and three of the structural proteins, M, E, and N,
were expressed as HA-tagged fusion proteins in mammalian
cells. Another two unique SARS-CoV proteins with 100 aa,
U154 (named ORF4 in reference 31, X2 in reference 38, and
ORF3b in references 45 and 52) and U122 (named ORF8 in
reference 31, X4 in reference 38, and ORF7a in references 45
and 52), were also tested. The expression levels of these pro-
teins, which have the HA epitope fused either at the C termi-
nus (U274-HA, U122-HA, M-HA, E-HA, and U154-HA) or
the N terminus (HA-GST and HA-N), were showed in Fig. 1B
(upper panel). The proteins that contain potential signal pep-
tides are tagged at the C terminus to minimize any effects on
their processing; otherwise, they are tagged at the N terminus.
When the anti-U274 rabbit polyclonal antibody was used
against these proteins, it recognizes U274 specifically in West-
ern blot analysis, and there is no significant cross-reactivity to
the other SARS-CoV proteins tested (Fig. 1B, lower panel).
GST protein was also detected since a GST fusion protein was
used for immunization.
Expression of U274 in SARS-CoV-infected Vero E6 cells.
SARS-CoV 2003VA2774, an isolate from a SARS patient in
Singapore, was used to infect Vero E6 cells as previously de-
scribed (33, 40, 51). Infected cells showing 25 and 75% CPE,
respectively, were harvested, lysed, and subjected to Western
blot analysis with the anti-U274 antibody (Fig. 2A). Interest-
ingly, three major protein bands (U274-a, -b, and -c) were
observed in the infected cells that have 75% CPE (lane 5) but
not in mock-infected cells (lane 3). Some weak signal was also
observed in the infected cells that have shown 25% CPE (lane
4). The highest protein band (U274-a) at 35 kDa migrated at
the same rate as U274 full-length protein expressed from a
DNA construct (lane 1), suggesting that this is the full-length
U274 expressed in infected cells. The two lower protein bands
(U274-b and -c) could be processed forms of U274 containing
the C terminus domain that is recognized by the antibody.
An analysis of the RNA sequences of sgRNA3 isolated from
infected Vero E6 cells showed that all of the clones contained
insertions in a six-T stretch at 16 to 21 bp downstream of the
ATG initiation codon of U274 (Fig. 2B). Of 15 independent
clones, the percentages of clones containing seven, eight, and
nine T’s are 20, 53, and 27%, respectively. An insertion of
three extra T nucleotides would result in an extra phenylala-
nine residue at eight residues from the N terminus of the
protein, and the highest protein band observed in infected cells
is likely to have been produced from the sgRNA3 containing
nine T’s in this region. The cellular localization of U274 is not
affected by this additional residue (data not shown). On the
other hand, an insertion of one or two T nucleotides in this
region would result in premature stop codon at 20 or 18 resi-
dues from the N terminus of U274, respectively. However,
these proteins would not be recognized by the U274 antibody,
which was raised against the C terminus of U274. Several
alternative initiation codons are found within the sgRNA3
sequences, but only two of them have the same reading frames
as U274 and produce proteins that could be recognized by the
U274 antibody. The first one translated into a protein of 270
aa, i.e., lacking the first 4 aa of U274, and would have a
molecular size very similar to that of U274 (data not shown).
The second one translated into a protein of 174 aa (termed
U274mut1 in the present study), and this corresponded to the
last 174 aa of U274 and would be recognized by the anti-U274
antibody. The U274mut1 protein expressed from a DNA con-
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struct migrated at the same rate as the lowest protein band
(U274-c) observed in the infected cells (Fig. 2A, lanes 2 and 5),
indicating that this truncated from of U274 can be expressed in
the infected cells from sgRNA3, including those containing
one or two T insertions. It is not clear how the second band
(U274-b) observed in the infected cells arises, but it could be a
processed form of full-length U274. In the present study, we
refer to the U274 with six T’s as full-length U274.
Anti-U274 rabbit polyclonal antibody was used in indirect
immunofluorescence experiments to determine the localiza-
tion of U274 in SARS-CoV-infected Vero E6 cells. As shown
in Fig. 3A, clusters of cells expressing U274 can be detected in
cells that have been infected with SARS-CoV, and no signifi-
cant staining was observed in mock-infected cells (data not
shown). Double labeling with a mouse polyclonal antibody
against SARS-CoV S protein (S. Shen, unpublished data), a
structural protein that is critical for viral assembly and pack-
aging of coronavirus (for review, see reference 9), and anti-
U274 antibody revealed that both proteins were expressed at
high level in the same clusters of cells (Fig. 3A to C). In
addition, the localization of U274 in infected cells (higher
magnification, Fig. 3D) is similar to that observed in cells
transfected with U274 (Fig. 3E).
Two fusion forms of U274 were also used in the present
study. U274-HA refers to full-length U274 with three HA
epitopes at the C terminus, and myc-U274 refers to full-length
U274 with a c-myc epitope at the N terminus. As shown in Fig.
3F and G, the cellular localizations of these forms of U274 are
similar to that of untagged U274 (Fig. 3E), indicating that
these epitopes do not affect the processing of the protein.
Efficient transport of U274 to the cell surface. Indirect im-
munofluorescence showed that U274 is localized to the perinu-
clear region, as well as to the plasma membrane of transfected
and infected cells (see Fig. 3, where cells have been perme-
abilized with Triton X-100). To determine the topology of
U274, Vero E6 cells were transfected with myc-U274 and an-
alyzed with either an anti-myc monoclonal antibody, which
recognizes the N terminus of the protein, or the anti-U274
rabbit polyclonal antibody, which recognizes the C terminus of
the protein. In unpermeabilized cells, anti-myc antibody clearly
FIG. 1. Rabbit polyclonal antibody specific for U274, the first ORF in the second largest subgenomic RNA of SARS-CoV. (A) Schematic
diagram showing the predicted topology of U274; (B) Western blot analysis of various HA-tagged SARS-CoV viral proteins expressed in
mammalian cells and probed with an anti-HA polyclonal antibody (upper panel) or the anti-U274 rabbit polyclonal antibody (lower panel).
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stained the cell surface of transfected cells (Fig. 4A, lower
panel, first column), whereas no signal was observed with anti-
U274 rabbit antibody (Fig. 4A, upper panel, first column),
suggesting that the N terminus of U274 is on the extracellular
side of the plasma membrane and the C terminus is facing the
cytoplasm (cf. Fig. 1A). When the cells were permeabilized
with digitonin, which selectively permeabilized the plasma
membrane (46), plasma membrane stainings were observed
with both antibodies (Fig. 4A, upper and lower panels, second
column). Similarly, in cells that were permeabilized with Triton
X-100, both cell surface and intracellular stainings were ob-
served with both antibodies (Fig. 4A, upper and lower panels,
third column).
FACS analysis was also performed to determine whether
myc-U274 could be expressed on the surface of live cells. As
shown in Fig. 4B (upper panel), an increase in surface fluores-
FIG. 2. Expression and processing of U274 in SARS-CoV-infected Vero E6 cells. (A) Western blot analysis with anti-U274 rabbit polyclonal
detected three protein bands in SARS-CoV-infected cells showing 25% (lane 4) and 75% (lane 5) CPE but not in mock-infected cells (lane 3).
The highest (marked as U274-a) and lowest (marked as U274-c) molecular mass proteins in the infected cells migrated at the same rate as
full-length U274 (lane 1) and U274mut1, which corresponds to the last 174 aa of U274 (lane 2), respectively. (B) Reverse transcription-PCR
products obtained with RNA from infected cells were ligated into pCRII-TOPO vector and sequenced. Chromatographs showed that stretches of
seven, eight, and nine T’s were present in this region of sgRNA3, which corresponded to 16 to 21 bp downstream of the initiation codon (ATG)
of U274. Analysis of the sequences of 18 different SARS-CoV isolates showed that all of them only have six T’s in this region. The percentages
of independent clones with the respectively number of T nucleotides are shown on the left.
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cence was observed when Vero E6 cells expressing myc-U274
were incubated with anti-myc monoclonal antibody (open his-
togram) compared to when these cells were incubated with an
irrelevant antibody of the same isotype (solid histogram). Cells
expressing myc-GST or myc-N did not show any increase in
surface fluorescence (Fig. 4B, upper panel). In addition, a
U274 mutant (U274mut2) that lacks sorting signals in the
cytoplasmic domain (see Table 1 and Discussion) was also not
transported to the cell surface, suggesting that this domain is
essential for the transportation of U274 to the cell surface.
Protein expression levels were determined by Western blot
analysis (lower panel).
U274 expressed on the cell surface can undergo endocytosis.
The C-terminal cytoplasmic domain of U274 contains a Yxx	
motif, which may be important for rapid internalization of the
protein from the plasma membrane (for a review, see refer-
ence 56). As shown in Fig. 5 (lanes 3 and 4, upper panel), Vero
E6 cells expressing myc-U274 were able to bind and internalize
antibody in the culture medium into the cells since a high
percentage of the antibodies were found to be internalized and
cannot be washed away with the acid. There was no detectable
unspecific binding of anti-myc antibody to Vero E6 cells trans-
fected with myc-GST (upper panel, lanes 1 and 2). The exper-
iment was repeated with anti-human CD81 and anti-human
TfR antibodies to compare the internalization efficiency of
U274 with these cell surface receptors. It has been shown that
CD81 has poor internalization efficiency (37, 49), whereas TfR
undergoes rapid internalization (for a review, see reference
FIG. 3. Cellular localization of U274 in infected and transfected Vero E6 cells as determined by indirect immunofluorescence. (A) SARS-
CoV-infected cells stained with anti-U274 rabbit polyclonal antibody; (B) SARS-CoV-infected cells stained with anti-S mouse polyclonal antibody;
(C) overlay of panels A and B showing cells that are expressing both S and U274 proteins (yellow); (D) SARS-CoV-infected cells (higher
magnification); (E) Vero E6 cells transfected with untagged U274; (F) Vero E6 cells transfected with U274-HA; (G) Vero E6 cells transfected with
myc-U274. Panels D to G are stained with anti-U274 rabbit polyclonal antibody.
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FIG. 4. Detection of myc-U274 on the cell surface by indirect immunofluorescence and FACS analysis. (A) Vero E6 cells transiently transfected
with myc-U274 were stained with either the anti-U274 rabbit polyclonal antibody (upper panel) that recognizes the C terminus of the protein or
anti-myc monoclonal antibody (lower panel) that recognizes N terminus of the protein. Cells were fixed with 4% paraformaldehyde and used
directly (no permeabilization) or permeabilized with digitonin or permeabilized with Triton X-100 before incubation with antibodies. (B) FACS
analysis of live Vero E6 cells transfected with myc-U274, myc-U274mut2, myc-GST, or myc-N. Cells were incubated with a myc-monoclonal
antibody (unfilled histogram) or an irrelevant antibody of the same isotype (filled histograms), followed by the addition of FITC-conjugated goat
anti-mouse F(ab)2 antibody. Surface expression of myc-U274 caused an increase in surface fluorescence upon staining with myc-monoclonal
antibody. The expression levels of the proteins were determined by Western blot analysis (with anti-myc antibody).
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56). As shown in Fig. 5 (upper panel, lanes 5 and 6), anti-CD81
antibodies bound to the surface of untransfected Vero E6 cells
but was not internalized as an acid wash efficiently remove all
of the surface-bound CD81 antibodies. Anti-human TfR anti-
body did not bind to Vero E6 cells (Fig. 5, upper panel, lanes
7 and 8), probably due to species difference for this gene.
Therefore, the experiment was repeated by using Vero E6 cells
transfected with a cDNA encoding for full-length human TfR
(Fig. 5, upper panel, lanes 9 and 10), and the results showed
that TfR is efficiently internalized as expected.
The same set of experiments was repeated with HeLa cells,
which express high levels of endogenous CD81 and TfR.
Again, HeLa cells transfected with myc-U274 were able to
internalize anti-myc antibodies (Fig. 5, upper panel, lanes 11
and 12) just like endogenous TfR (Fig. 5, upper panel, lanes 15
and 16), whereas CD81 did not undergo efficient internaliza-
tion (Fig. 5, upper panel, lanes 13 and 14). The expression
levels of myc-GST and myc-U274 were determined by using an
anti-myc polyclonal antibody (Fig. 5, second panel), and the
expression levels of TfR were determined by using anti-TfR
antibody. Anti-actin antibody (Fig. 5, lowest panel) was used to
check for equal loading.
Interaction of U274 with other SARS-CoV proteins. Coim-
munoprecipitation experiments were performed to determine
whether U274 could interact with the SARS-CoV structural
proteins M, E, and N. As shown in Fig. 6A (upper panel),
myc-U274 specifically coimmunoprecipitated E-HA (lane 6)
and M-HA (lane 8), and neither of these showed any nonspe-
cific binding to myc-GST (lanes 5 and 7). HA-N did not inter-
act with myc-U274 or myc-GST (lanes 1 and 2). U274 also
interacts strongly with U122 (lanes 3 and 4), another unique
SARS-CoV protein that is expressed in infected cells (B. Field-
ing, unpublished data).
In order to determine whether myc-U274 can interact with
the S protein, the cells were transfected with myc-U274 and an
untagged S construct, since the addition of HA tags to S re-
sulted in poor expression (data not shown). After immunopre-
cipitation with anti-myc antibodies, the amount of S bound to
myc-U274 or myc-GST was determined by using an anti-S
mouse polyclonal antibody. As shown in Fig. 6B (upper panel),
the S protein of180-kDa interacts specifically with myc-U274
but not with myc-GST.
DISCUSSION
The sequence of the SARS-CoV reveals ORFs for the rep-
licase gene 1a/1b and four structural proteins: S, M, E, and N
(31, 38). These genes are expected to be essential for viral
replication and are present in all coronaviruses (for reviews,
see references 12, 24, 25, and 43). Besides these, there are
numerous unique ORFs predicted from the SARS-CoV se-
quence (31, 38, 52). In the present study we analyzed the first
ORF (termed U274 here) of sgRNA3 to determine whether it
is expressed during viral infection and whether it serves a
function in the viral replication cycle.
Using specific antibodies against U274 and S proteins, we
showed by immunofluorescence that both of these proteins are
expressed at high levels in Vero E6 cells that were infected by
the SARS-CoV (Fig. 3). In infected cells, three forms of U274
could be detected by Western blot analysis: full-length U274
and two shorter products containing the same C terminus as
the full-length protein (Fig. 2A). These shorter products may
be have been processed from the full-length or could have
translated from alternative initiation codons within the U274
encoding sequence. In addition, we also observed insertions in
a six-T-nucleotide region found 16 to 21 bp downstream from
the initiation codon of U274 (Fig. 2B). Analysis of the se-
quences of 18 different SARS-CoV isolates (obtained from
GenBank database) revealed that none of them show insertion
in this region, suggesting that this mutation may be specific to
this particular laboratory strain of SARS-CoV. Alternatively, it
may only be present at later passages since the third passage
was used in the present study, whereas the previously reported
sequence of this isolate contained only six T’s and was deter-
mined at the first passage (SIN2774; GenBank accession no.
AY283798 [40]). Alternatively, this may be due to errors dur-
ing reverse transcription or PCR.
In both transfected and infected cells, U274 is localized to
the perinuclear region as well as to the plasma membrane (Fig.
3). Immunofluorescence analysis on cells expressing U274 with
TABLE 1. Comparison of Yxx	 and diacidic motifs found in the cytoplasmic domain of SARS-CoV U274 protein to those found in other
known transmembrane proteinsa
Protein NCBI identifier (no.) Yxx	 and (D/E)(E/D) motif
U274 Virus (37361915) TM-38aa-YNSVTDTIVVTEGD-101aa
VSV-G Virus (138311) TM-18aa-YTDIEMNRLGK
VZV-GPI Virus (138246) TM-20aa-YAGLPVDDFEDSESTDTEEEF
TfR Human (136378) 19aa-YTRFSLARQVDGDNSHV-26aa-TM
LDLR (proximal) Human (126073) TM-17aa-YQKTTEDEVHICH-20aa
LDLR (distal) Human (126073) TM-34aa-YSYPSRQMVSLEDDVA
CI-M6PR Mouse (1709091) TM-26aa-YSKVSKEEETDENE-127aa
CD-M6PR Mouse (127294) TM-34aa-YRGVGDDGLGEESEERDDHLLPM
ASGPR (H1 subunit) Human (126132) MTKEYQDLQHLDNEES-24aa
CD3
 Mouse (115986) TM-21aa-YQPLRDREDTQ-14aa
CD3 Mouse (115994) TM-21aa-YQPLKDREYDQ-12aa
LAP Human (130727) TM-8aa-YRHVADGEDHA
a The Yxx	 motif is underlined, and the acidic residues conforming to the diacidic [(D/E)(E/D)] signal are in boldface. Sequences were obtained from National
Center for Biotechnology Information (NCBI). Abbreviations: VSV-G, vesicular stomatitis virus glycoprotein; VZV-GPI, varicella-zoster virus glycoprotein; LDLR,
low-density lipoprotein receptor; CI-M6PR, cation-independent mannose 6-phosphate receptor; CD-M6PR, cation-dependent mannose 6-phosphate receptor; AS-
GPR, asialoglycoprotein receptor. aa, amino acid(s).
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a myc tag at the N terminus, by using either anti-myc mono-
clonal antibody or anti-U274 antibody that recognizes only the
C terminus of U274, confirmed the topology of U274: its N
terminus is facing the extracellular matrix, and its C terminus
is facing the cytoplasm (Fig. 1A and 4). Interestingly, U274 is
predicted to have a similar topology since M (31) and our data
are consistent with the predicted topology but have not proven
the presence of three transmembrane domains in U274. These
results confirmed that U274 is a novel SARS-CoV protein that
can be transported efficiently to the cell surface of infected
cells. This would explain why anti-U274 antibodies were found
in the majority of SARS patients (51).
Both S and HE proteins are transported to the cell surface
in virus-infected cells and when expressed alone (20, 35, 57).
Similarly, the E protein was observed in granular or punctuate
cytoplasmic structures, as well as at the plasma membrane (15,
44, 60). On the other hand, when expressed alone, the M
protein is found in the Golgi (for a review, see reference 39).
However, when M is coexpressed with E, the two proteins form
virus-like particles that are morphologically identical to spike-
less virions and are released into the medium (2, 4, 10, 29, 59).
For coronavirus, the viral envelope that packages the nucleo-
capsid is derived from the membrane of the intracellular bud-
ding site, which is the endoplasmic reticulum-Golgi interme-
diate compartment or cis-Golgi network (21, 22, 41, 55). After
budding, virions are thought to move in vesicles through the
secretory pathway and to exit the cells when these vesicles fuse
with the plasma membrane (19, 53, 54). However, the exact
mechanism(s) for viral release remains unknown, and it is not
clear how the viral proteins (S, HE, or E) on the cell surface
participate in this process (for reviews, see references 12, 24,
25, and 43).
FIG. 5. Internalization of antibodies by U274 and other cell surface receptors. Cells transfected with myc-GST (lanes 1 and 2 for Vero E6) or
myc-U274 (lanes 3 and 4 for Vero E6 and lanes 11 and 12 for HeLa) were incubated with an anti-myc monoclonal antibody for 3 h at 37°C, followed
by PBS washes or PBS-acid washes, and then the cells were harvested and lysed in Laemmli SDS buffer and subjected to Western blot analysis.
The cell lysate for cells that were only washed with PBS would contain both surface-bound and internalized antibody (total). For cells that were
subjected to an additional acid wash remove surface-bound antibody, the lysate would contain antibody that has been internalized (internalized).
The heavy chains of the surface bound and internalized antibody (IgG heavy chains, upper panel) were detected by Western blotting. To compare
the internalization efficiency of U274 with CD81 and TfR, the cells were overlaid with anti-human CD81 (lanes 5 and 6 for Vero E6 cells and lanes
13 and 14 for HeLa cells) or anti-human TfR (lanes 9 and 10 for Vero E6 cells transfected with a cDNA encoding for full-length human TfR and
lanes 15 and 16 for HeLa cells) antibodies, and the amounts of total versus internalized antibodies were determined as described above. Expression
levels of myc-GST or myc-U274 were determined by using anti-myc antibody (second panel). Expression levels of TfR were determined by using
anti-TfR antibody (third panel). The level of endogenous actin protein was used to check for equal loading (lowest panel). This experiment was
repeated three times, and similar results were obtained each time. A representative set of data is presented.
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Analysis of the C-terminal cytoplasmic domain of U274 re-
vealed that it contains a Yxx	 (where x is any amino acid and
	 is an amino acid with a bulky hydrophobic side chain) up-
stream of a ExD (diacidic) motif (see Table 1). The diacidic
motif is required for efficient endoplasmic reticulum export
(34), whereas the Yxx	 motif has been implicated in directing
protein localization to various intracellular compartments (for
reviews, see references 3, 30, and 56). Furthermore, most Yxx	
motifs are capable of mediating rapid internalization from the
plasma membrane into the endosomes (for reviews, see refer-
ences 3, 30, and 56). Interaction between the adaptor protein
complex 2 (AP-2) with the Yxx	 motif present in the cytoplas-
mic domain of the internalizing protein concentrated the pro-
tein in the clathrin-coated vesicle, which then budded from the
plasma membrane, resulting in internalization (for reviews, see
references 3, 30, and 56). However, it appears that the Yxx	
FIG. 6. Interactions between U274 and other SARS-CoV proteins. (A) Cell lysates containing myc-GST or myc-U274 with either HA-N,
U122-HA, E-HA, M-HA, or U274-HA proteins were immunoprecipitated with myc-polyclonal antibody and protein A-beads. The amounts of
HA-tagged proteins that coimmunoprecipitated (IP) with myc-GST (lanes 1, 3, 5, and 7) or myc-U274 (lanes 2, 4, 6, and 8) were determined with
an anti-HA monoclonal antibody (upper panel). Expression levels of the HA-tagged proteins were determined by subjecting aliquots of the lysates
before immunoprecipitation to Western blot analysis (WB, middle panel). The first blot containing the immunocomplexes (i.e., upper panel) was
stripped and reprobed with an anti-myc monoclonal antibody to determine the amount of myc-tagged proteins immunoprecipitated (lower panel).
(B) Expression (before IP) and coimmunoprecipitation (after IP) of untagged S protein with myc-GST or myc-U274 were determined with an
anti-S mouse polyclonal antibody (upper panel). Expression levels of myc-GST and myc-U274 in the lysates were determined by using anti-myc
monoclonal antibody (before IP, lower panel).
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motif can also bind other adaptor protein complexes, such as
AP-1, -3, and -4, and the differential binding to the different
adaptors will determine the pathway of a cargo protein con-
taining a particular Yxx	 motif (for a review, see reference 3).
Interestingly, the juxtaposition of these two different sorting
motifs, i.e., the diacidic and Yxx	 motifs, have been found in
the cytoplasmic tails of a number of plasma membrane pro-
teins (for a review, see reference 1), suggesting that this may be
important for transport of proteins to the plasma membrane.
In the case of VSV-G, these domains overlapped and the
efficient export of VSV-G from the endoplasmic reticulum
requires both motifs (42). Indeed, deletion of these motifs
from U274 (U274mut2) abolished the transport of U274 to the
cell surface (Fig. 4B), suggesting that they are important for
the exit of U274 from the endoplasmic reticulum and/or the
subsequent transport to the plasma membrane. Further exper-
iments demonstrated that U274 (with a myc tag at the N
terminus) expressed on the cell surface was able to internalize
anti-myc antibody from the culture medium into the cells, with
a efficiency comparable to that of TfR (Fig. 5). The same
results were obtained in both Vero E6 and HeLa cells, i.e., the
internalization of U274 is not cell type specific (Fig. 5). Of
note, an analysis of the sequences of 22 SARS-CoV isolates in
the GenBank database, including the four (SZ1, SZ3, SZ13,
and SZ16 [16]) that were recently isolated from market ani-
mals, showed that these two motifs of U274 are conserved in
all but one. The only exception is GZ01 (GenBank accession
no. AY278489), in which the ExD motif was AxD instead. It
would be interesting to examine how the profile of U274 in this
particular isolate differs from the others.
In conclusion, U274 is a novel SARS-CoV protein that can
be transported efficiently to the cell surface of infected and
transfected cells, and its cytoplasmic domain contained sorting
signals that are important for this process. U274 expressed on
the cell surface can also undergo endocytosis. It is intriguing to
find that SARS-CoV has evolved to express a viral protein with
endocytotic properties since endocytosis has been shown to
play important roles in the replication of and adaptation to the
host cell of a number of viruses (for a review, see reference 32).
Taken together, with its ability to interact specifically with
proteins M and E, which are two key players in the viral
assembly of coronaviruses, as well as with the S protein (Fig.
6), it appears that U274 may play a role in viral assembly
and/or release of virus from infected cells. Studies on the
mouse hepatitis virus, a member of coronavirus group 2, have
also shown that replicase gene products colocalized with struc-
tural proteins N and M at different times of infection, indicat-
ing that these structural and nonstructural viral proteins can
form multiple complexes in infected cells (5, 6). Based on our
observation that U274 interacts with U122, which is yet to be
characterized, and with the structural proteins (M, E, and S), it
is logical to hypothesize that these viral proteins may form
multiple complexes in SARS-CoV-infected cells and that the
formation of these complexes may be important for viral as-
sembly. This hypothesis will be the subject of future studies. In
addition, it will be important to determine the precise role of
U274 in the biogenesis of SARS-CoV and to determine
whether it has any effects on the host cells during an infection.
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